PFKFB3 controls acinar IP3R-mediated Ca2+ overload to regulate acute pancreatitis severity
Open Access
- 23 May 2024
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (13)
Abstract
Acute pancreatitis (AP) is among the most common hospital gastrointestinal diagnoses; understanding the mechanisms underlying the severity of AP is critical for development of new treatment options for this disease. Here, we evaluate the biological function of phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) in AP pathogenesis in 2 independent genetically engineered mouse models of AP. PFKFB3 was elevated in AP and severe AP (SAP), and KO of Pfkfb3 abrogated the severity of alcoholic SAP (FAEE-SAP). Using a combination of genetic, pharmacological, and molecular studies, we defined the interaction of PFKFB3 with inositol 1,4,5-trisphosphate receptor (IP3R) as a key event mediating this phenomenon. Further analysis demonstrated that the interaction between PFKFB3 and IP3R promotes FAEE-SAP severity by altering intracellular calcium homeostasis in acinar cells. Together, our results support a PFKFB3-driven mechanism controlling AP pathobiology and define this enzyme as a therapeutic target to ameliorate the severity of this condition.Keywords
Funding Information
- the Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars (BK20200004)
- National Key Research and Development Program of China (2018YFA0900803)
- National Natural Science Foundation of China (3217080376, 81900583, 81770630, 31870912, 31771560, 31670883, 8210140220, 81570583)
- CAMS Innovation Fund for Medical Sciences (CIFMS2021-I2M-1-047, 2021-I2M-1-061, 2022-I2M-2-004)
- Non-profit Central Research Institute Fund of CAMS (2019PT310028)
- National Key Research and Development Program of China (2023YFE0118000)
- Department of Oncology (/)
- CAMS Innovation Fund for Medical Sciences (2023-I2M-2-010)
This publication has 49 references indexed in Scilit:
- Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatmentBioactive Materials, 2021
- PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationshipsEuropean Journal of Medicinal Chemistry, 2020
- New Insights in the IP3 Receptor and Its Regulation2019
- Mass Spectrometry-based Label-free Quantitative Proteomics To Study the Effect of 3PO Drug at Cellular LevelACS Medicinal Chemistry Letters, 2019
- Research Progress on the Relationship Between Acute Pancreatitis and Calcium Overload in Acinar CellsDigestive Diseases and Sciences, 2018
- The Glycolytic Enzyme PFKFB3 Controls TNF-α-Induced Endothelial Proinflammatory ResponsesInflammation, 2018
- Lipase or amylase for the diagnosis of acute pancreatitis?Clinical Biochemistry, 2017
- The role of fat and alcohol in acute pancreatitis: A dangerous liaisonPancreatology, 2015
- Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3Journal of Medicinal Chemistry, 2015
- Ca2+ signalling and pancreatitis: effects of alcohol, bile and coffeeTrends in Pharmacological Sciences, 2006